^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    modakafusp alfa (TAK-573)

    i
    Associations
    News
    Trials
    Company:
    Takeda
    Drug class:
    CD38 inhibitor, IFNα stimulant
    Related drugs:
    Associations
    News
    Trials